Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Central Nervous System Neoplasms 12Astrocytoma 10Brain Neoplasms 9Lymphoma, Non-Hodgkin 8Gliosarcoma 8Glioblastoma 8Oligodendroglioma 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma 7Glioma 7Lymphoma, Mantle-Cell 6Lymphoma, Follicular 5Burkitt Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Ependymoma 4Recurrence 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, B-Cell, Marginal Zone 3Hodgkin Disease 3Neuroectodermal Tumors, Primitive 2Multiple Myeloma 2Medulloblastoma 2Lymphoma, B-Cell 2Unspecified Adult Solid Tumor, Protocol Specific 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pediatric Brain Tumor 1

Interventions

Temozolomide 8Filgrastim 5Carboplatin 5Peripheral Blood Stem Cell Transplantation 3O(6)-benzylguanine 3Etoposide 3Vorinostat 2Vincristine 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2Bortezomib 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2veliparib 1temsirolimus 1romidepsin 1palbociclib 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1exatecan 1etoposide phosphate 1entinostat 1carboxyamido-triazole 1azurin (50-77) 1Verteporfin 1Topotecan 1Thiotepa 1Thalidomide 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Choroid Plexus Neoplasms × Carmustine × Clear all
NCT00003765 2013-02-05

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡